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Abstract
Background—Children with asthma face higher risk of complications from influenza. Trends in 
influenza vaccination among children with asthma are unknown.
Methods—We used 2005–2013 National Health Interview Survey data for children 2 to 17 years 
of age. We assessed, separately for children with and without asthma, any vaccination (received 
August through May) during each of the 2005–2006 through 2012–2013 influenza seasons and, 
for the 2010–2011 through 2012–2013 seasons only, early vaccination (received August through 
October). We used April–July interviews each year (n = 31,668) to assess vaccination during the 
previous influenza season. Predictive margins from logistic regression with time as the 
independent and vaccination status as the dependent variable were used to assess time trends. We 
also estimated the association between several sociodemographic variables and the likelihood of 
influenza vaccination.
Results—From 2005 to 2013, among children with asthma, influenza vaccination receipt 
increased about 3 percentage points per year (P < .001), reaching 55% in 2012–2013. The 
percentage of all children with asthma vaccinated by October (early vaccination) was slightly 
above 30% in 2012–2013. In 2010–2013, adolescents, the uninsured, children of parents with 
some college education, and those living in the Midwest, South, and West were less likely to be 
vaccinated.
Conclusions—The percentage of children 2 to 17 years of age with asthma receiving influenza 
vaccination has increased since 2004–2005, reaching approximately 55% in 2012–2013.
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Annual influenza vaccination is recommended by the Advisory Committee on Immunization 
Practices (ACIP) for all children more than 6 months of age.1 However, ACIP and others 
have historically regarded the influenza vaccination as particularly important for children 
with asthma because of their increased risk for severe complications from influenza 
compared to children without asthma.2,3 Although asthma is one of several medical 
conditions that ACIP suggests confers higher risk on children,3 asthma represents one of the 
most prevalent chronic conditions among children, with approximately 9.3% of children, or 
more than 6.8 million children, with a current diagnosis of asthma in 2012.4 Further, 
patterns of vaccine use may differ for children with different medical conditions, so 
examination of vaccination among children with asthma is of interest.5 ACIP also 
recommends early vaccination, preferably by October, for all children, including those with 
asthma, to confer protection during the entire influenza season.1
Although influenza vaccination has been recommended for children with asthma and other 
chronic conditions since before 1990,6 recommendations for children without chronic 
conditions have changed over time. In 2004, influenza vaccination was recommended for all 
children 6 to 23 months of age as well as their household contacts.7 In 2006, the 
recommendation was expanded to all children 6 months to younger than 5 years of age.8 
Starting with the 2008–2009 season, the recommendation was further expanded to include 
all children >6 months of age (barring contraindication).9
Previous assessments of influenza vaccination among children with asthma are sparse. One 
study examined the rate of influenza vaccination among children with asthma for the 1995–
1997 influenza season among children enrolled in 4 health maintenance organizations on the 
West Coast of the United States, finding that approximately 10% of children with asthma 
received an influenza vaccination during each season.10 To our knowledge, Brim et al11 was 
the first to provide national population-level estimates of influenza vaccination coverage 
among children with asthma, examining the 2004–2005 influenza season and finding that 
the influenza vaccination rate was 29.0% among children 2 to 17 years of age with asthma 
and 10.3% among those without asthma. Although recent research has shown that coverage 
has increased since then among children with and without chronic conditions,12 influenza 
vaccination among children with asthma specifically has not been evaluated since the 2004–
2005 season, and trends over time are unknown.11 In addition, the percentage of children 
with asthma who receive early influenza vaccination has not been examined.
In this study, we use nationally representative data to examine influenza vaccination among 
children 2 to 17 years of age from the 2004–2005 through the 2012–2013 influenza seasons, 
and we assess whether vaccination trends differ by asthma status. Also, we assessed, among 
children with asthma, which characteristics were associated with receiving any influenza 
vaccination and with receiving influenza vaccination early in the season (by the end of 
October).
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Data are from the 2005–2013 National Health Interview Survey (NHIS), a nationally 
representative survey with a complex sample design, administered by the National Center 
for Health Statistics (NCHS). Data were from in-house NCHS files, which can be accessed 
in the NCHS Research Data Center. Within each participating family, one child 0 to 17 
years of age (the sample child) was randomly selected, and health-related information was 
obtained from in-person interviews with a knowledgeable adult (usually a parent). The 
NHIS 2005–2013 sample child questionnaires included questions about the year and month 
of the child’s most recent influenza vaccinations. Response rates for the NHIS sample child 
component ranged from 78.8% in 2006 to 69.0% in 2013.13 The NHIS was approved by the 
NCHS Research Ethics Review Board; this study did not require separate institutional 
review board approval.
Identification Of Children With Asthma
Current asthma status was based on affirmative responses to both of 2 questions: “Has a 
doctor ever told you that your child had asthma?” and “Does your child still have asthma?” 
We excluded children <2 years of age, given the difficulty of diagnosing asthma in this age 
group.14
Identification Of Influenza Vaccination
During 2005–2009, the respondent was asked whether the child had received an influenza 
vaccination injection in the last 12 months and, if so, when the most recent influenza 
vaccination injection was. Then the respondent was asked whether the child had received an 
influenza vaccine by nasal spray (Flumist/Live Attenuated Virus vaccine) in the last 12 
months. Children <9 years of age receiving the influenza vaccine for the first time should 
receive 2 doses of influenza vaccine, spaced at least 1 month apart.1 Consequently, for 
children <9 years of age interviewed late in the season, the most recent influenza vaccination 
reported could be a second dose, creating a bias toward being identified as a later 
vaccination compared to when the initial vaccination actually occurred. Therefore, data from 
2005–2009 were not included in our analyses estimating early vaccination.
For the 2010–2013 seasons, the NHIS questions were revised to assess whether a child had 
received any influenza vaccine in the last 12 months, how many vaccines they had received, 
when they received each vaccine, and whether each vaccine was an injection or a nasal 
spray. This new questionnaire structure allowed for determination of whether the first 
vaccination (if multiple vaccinations were reported) was received early or late in the 
influenza season. Vaccinations received during August through the following May were 
categorized as occurring during that influenza season. Vaccinations received during August 
through October were categorized as early vaccination. During the 2009–2010 influenza 
season, when both the seasonal trivalent influenza vaccine and the monovalent pandemic 
H1N1 vaccine were administered, NHIS asked about these 2 vaccinations separately. Only 
the seasonal trivalent influenza vaccine was used in our analysis because inclusion of either 
vaccination for the 2009–2010 season would have created an outlier from the overall 
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vaccination trend.15 Live attenuated influenza vaccination and inactivated influenza 
vaccination are included together in all analyses. We examined the percentage of children 
receiving live attenuated influenza vaccine, but the percentage of children was too low 
among children with asthma to obtain separate statistically reliable estimates from these 
data. Because the focus of this study was to examine trends among children with asthma, we 
did not separately report estimates of live attenuated influenza vaccine for children without 
asthma.
Covariates
We included the following sociodemographic/geographic factors in our analysis on the basis 
of previously identified factors related to influenza vaccination in children10,12,16: age group 
(2–5, 6–11, 12–17 years), sex, race/ethnicity (non-Hispanic white, non-Hispanic black, non-
Hispanic other/multiple race, Hispanic), insurance type (private insurance, Medicaid/State 
Children’s Health Insurance Program/other state insurance plan, other insurance, uninsured), 
highest level of parental education (less than high school, high school graduate/GED, some 
college/associates degree/technical school degree, college degree or more), urban or rural 
status based on NCHS urban–rural coding17 (large central–metro, large fringe–metro 
[suburbs], medium and small metropolitan areas, micropolitan and noncore areas), and 
geographic region (Northeast, Midwest, South, West). Measures of asthma severity were not 
available in the NHIS for the years used in this analyses, but a crude measure of asthma 
control was available and included in our analysis: whether the child had an asthma episode 
or attack in the past 12 months.
Statistical Analysis
At the time of the interview, respondents could report that the child had not yet have 
received a vaccine for that season, but the child could go on to be vaccinated that season 
after the date of the interview. This could result in misclassification (underreporting) of 
seasonal vaccination status. Two separate methodologies have previously been used to 
account for this issue and to estimate influenza vaccine coverage using the National Health 
Interview Survey.11,12 For the primary analysis in our study, we build on the approach of 
Brim et al,11 restricting our analysis to interview months during the spring and summer. 
Additionally, we conducted a second analysis consistent with the approach of Santibanez et 
al12 that relies on survival analysis to generate yearly estimates of influenza vaccination 
rates, including all interview months and censoring observations at the time of interview if 
an influenza vaccination had not yet occurred. Results from both approaches were similar; 
therefore, the methods and results from the second approach are presented in an online 
appendix (Online Appendix 1, Online Appendix Figure, Online Appendix Tables).
Brim et al11 estimated the cumulative incidence of influenza vaccination for a single season, 
but we extend their methodology to examine trends over several seasons.11 Analyses were 
limited to interviews conducted during April through July of each year, and identified 
whether a vaccination was received during the previous influenza season lasting August 
through May. Respondents in April–July were unlikely to be given the vaccine after the 
interview date because the current influenza season had ended. Because the NHIS sample is 
designed to be nationally representative for each calendar month, using only these 4 months 
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still provided national estimates. The percentage of children 2 to 17 years of age with and 
without asthma who received an influenza vaccine from August to May of each season was 
estimated. Logistic regression with receipt of influenza vaccination as the dependent 
variable and influenza season as the independent variable was used to examine time trends 
in vaccine receipt over the observed time period, and an interaction term for asthma status 
was used to examine whether trends differed by asthma status. A significant interaction term 
led to stratification by asthma status. After stratification, the addition of a quadratic term for 
influenza season was added to see if model fit could be improved using a curvilinear model. 
The quadratic term was only significant for the model of children without asthma and 
therefore is only presented for this group. Predictive margins from these regression models 
were used to estimate percentage point increases in vaccination rates per influenza season.
In addition, for 2010–2013, the percentage of children who received an early influenza 
vaccination (receiving their first influenza vaccination for the season during August 1 
through October 31) was estimated. Because only 3 seasons of early influenza vaccination 
data were available, no trend analysis was performed; however, the 2010–2011 and 2012–
2013 season vaccination estimates were compared by a Wald test. For the 2012–2013 
season, comparisons of vaccination rates between children with and without asthma were 
also conducted by a Wald test.
Among children with asthma, the cumulative incidence of influenza vaccination is presented 
by sociodemographic/geographic characteristics. Bivariate logistic regressions were used to 
estimate the odds ratios (ORs) for each characteristic for receiving any versus no influenza 
vaccine, and among the group of children who received vaccines, early versus late influenza 
vaccination. These 2 models provide different information. The analysis comparing 
influenza vaccine versus no influenza vaccine was designed to assess whether differences 
exist between those who consent to receive the influenza vaccine (even including late 
receivers) versus those who do not. The analysis comparing early versus late receivers 
among those who do agree to receive the influenza vaccine was designed to examine if 
certain characteristics were associated with receiving the vaccine early, as recommended.
Missing Data
Two non–mutually exclusive populations were used for analyses. First, the estimation of any 
vaccination included children 2 to 17 years of age at the time of interview during April 
through July of the years 2005–2013 (n = 3303 with asthma and 31,668 with and without 
asthma). Second, for analyses concerning early vaccination, only interviews from 2010–
2013 were included (n = 3303 with asthma, n = 10,132 with and without asthma). The 
percentage of observations missing data for asthma status was 0.2% for the 2005–2013 
sample and 0.3% for the 2010–2013 sample. The percentage of missing information on 
whether the child had an influenza vaccination during the previous 12 months was 3.1% for 
both the 2005–2013 sample and the 2010–2013 sample. In addition, of those who reported 
receiving a vaccination, the percentage missing information on the timing of the vaccine was 
9.8% for the 2005–2013 sample and 7.5% for the 2010–2013 sample. The exact number of 
missing observations for each sample is presented in Online Appendix 1 and Online 
Appendix Table 1. Missing values were multiply imputed with a conditional multiple 
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imputation by chained equations.18,19 Imputation models for vaccination status were logistic 
regressions and imputation models for year and month of vaccination (among those 
vaccinated) were predictive mean matching models.18,19 Online Appendix 1 contains more 
specific information concerning the multiple imputation methodology. Multiply imputed 
values were used in all analyses.
Results
Approximately 10% of children (standard error [SE] 0.2) had asthma across the 2005–2013 
influenza seasons (Online Appendix Table 2), or an average of approximately 6.6 million 
children during each influenza season.
Trends in Vaccination
The percentage of children with asthma receiving influenza vaccination increased, on 
average, 3.2 percentage points per year (SE 0.4; P < .001 for trend), reaching 54.7% (SE 
3.3%) in 2012–2013 (Figure). The percentage of children without asthma receiving 
influenza vaccination increased approximately 4.2 percentage points per year (SE 0.1; P < .
001 for trend), reaching 45.2% (SE 1.2%) in 2012–2013, a lower percentage than for those 
with asthma in 2012–2013 (P <.01).
The addition of a quadratic term to the model improved fit for children without asthma (P 
< .001 for quadratic term), but not for children with asthma. This model suggested that there 
was a steeper slope during earlier years for children without asthma, reaching a maximum 
increase of approximately 5.3 percentage points per year (SE 0.3) during the 2006–2007 
season and flattening to an increase of only 1.1 percentage points per year (SE 0.6) during 
2012–2013—an increase that was not significantly different than 0 (P = .08). In an overall 
model, including children with and without asthma, the significance of the interaction term 
(P <.001) between time and asthma status suggested statistically different trends for children 
with and without asthma. Overall estimates of the percentage of all children who have 
received influenza vaccination are closer to those for children without asthma because only 
approximately 10% of children had asthma during the study period. Overall, the percentage 
of all children 2 to 17 years old receiving influenza vaccination increased an average of 4.1 
percentage points per year (SE 0.1; P < .001 for trend), from 13.6% (SE 0.6%) during the 
2004–2005 influenza season to 46.2% (SE 1.1%) during the 2012–2013 influenza season.
Early Vaccination
Among children with asthma, the percentage receiving early influenza vaccination was not 
statistically different between 2010–2011 (29.9% [SE 2.7%]) and 2012–2013 (32.3% [SE 
3.1%]) (P = .57). Among children without asthma, the percentage receiving early influenza 
vaccination was higher in 2012–2013 (26.8% [SE 1.1%]) than in 2010–2011 (23.3% [SE 
0.9%]) (P = .02). In 2012–2013, no significant difference was found between the 
percentages of children receiving early vaccination by asthma status (P =.10).
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Characteristics Associated With Vaccination Among Children With Asthma
Receiving any influenza vaccination (as compared to no influenza vaccination) was less 
likely among children 12 to 17 years of age compared to children 2 to 5 years of age (OR 
0.52, P <.01); uninsured children compared to those with private insurance (OR 0.46, P =.
03); children of parents whose highest level of education was some college/associates 
degree/technical school compared to those with a college degree or more (OR 0.62, P = .02); 
and children who live in the Midwest, South, or West compared to those in the Northeast 
(OR 0.54, P <.01; OR 0.64, P =.03; and OR 0.61, P =.02; respectively). However, no 
characteristics were significantly associated with receiving an early versus late influenza 
vaccination among children with asthma (Table).
Discussion
Between 2005 and 2013, the percentage of children in the United States with asthma who 
received an influenza vaccination increased approximately 3 percentage points per year. The 
overall gain for children with asthma of approximately 23 percentage points (from 32% in 
2004–2005 to nearly 55% in 2012–2013) was smaller than the overall gain for children 
without asthma of 33 percentage points (from approximately 12% in 2004–2005 to 45% in 
2012–2013). The changes in the ACIP recommendations in 2006 and 2008, which expanded 
recommendations to include all children >6 months of age, may account for the greater 
increase among children without asthma during the observed time period. Despite the 
expanded recommendations, for 2012–2013, the percentage of children with asthma who 
received the influenza vaccination was still greater than that for children without asthma. In 
general, our results are similar to those from a recent analysis that evaluated trends from 
2004–2012 for children with high-risk medical conditions (which include asthma).12 
However, in contrast to other work, we observed that the rate of increase among children 
without asthma may have slowed, having reached a maximum rate of increase during 2006–
2007 and flattening by 2012–2013. Future years of data will be necessary to determine 
whether the rate of increase among children without asthma has indeed slowed.
Of note, during the 2012–2013 influenza season (the most recent season for which data were 
available), 45% of children with asthma and 55% of children without asthma did not receive 
an influenza vaccination. The Healthy People 2020 target (immunization and infectious 
disease objective number 12.11) for the percentage of children aged 6 months through 17 
years vaccinated annually against seasonal influenza, is 70%.20 This goal has not yet been 
reached.
The percentage of children with asthma who were vaccinated early in the season (by the end 
of October) was slightly above 30%, leaving 20% to 25% of children with asthma receiving 
their influenza vaccination later in the season than recommended. Whether the percentage of 
children with asthma who received early vaccination is increasing is unclear given the 
limited years of data available in our analysis. Early vaccination maximizes the chance that 
children will be vaccinated before the peak of the influenza season, which occurred in 
December or earlier 8 times between the 1982–1983 and the 2013–2014 seasons.21
Simon et al. Page 7













Many interventions to improve vaccination coverage have been explored,22,23 some which 
focus on all children24 and others of which focus more narrowly on children with asthma16 
and/or other chronic diseases.25,26 The extent to which trends observed in our study have 
resulted from interventions on the part of the medical or public health community, changes 
in reimbursement rates for influenza vaccination,27 changes in parental opinion concerning 
the influenza vaccine,28 or other factors is not known. Improved epidemiologic knowledge 
about groups that do not obtain influenza vaccination may be useful for public health 
practitioners and clinicians trying to improve vaccination coverage.
In this study, we find that among children with asthma, adolescents, the uninsured, children 
of parents with some college/associate degree/technical school, and those living in the 
Midwest, South, and West were less likely to be vaccinated for influenza. Among all 
children and among children with asthma, other researchers have also found lower rates of 
influenza vaccination among adolescents.11,12,29 Across the 3 most recent influenza seasons 
for which data were available, we did not find differences in vaccination rates by race/
ethnicity. However, Santibanez et al12 considered influenza seasons separately among all 
children and found several seasons for which Hispanic children had higher influenza 
vaccination rates than non-Hispanic white children. Whether these differences result from 
examining different populations or are due to different methodologies requires further 
research. National estimates of influenza vaccination among children with asthma 
categorized by other sociodemographic characteristics, to our knowledge, have not been 
previously presented.
Limitations
This study has some limitations. Receipt and timing of influenza vaccination were based on 
parent recall, which may overestimate influenza vaccination prevalence as a result of 
perceived social acceptability in reporting vaccination.30,31 Second, there was missing 
information for receipt and timing of influenza vaccination for some children. Although we 
addressed this limitation with multiple imputation, our initial models would not converge, 
and our subsequently simplified models excluded some covariates that may have improved 
model fit had convergence been achieved. Also, our findings regarding the association 
between vaccination and parents’ level of education are difficult to interpret, as an 
increasing level of vaccination across the education gradient was not observed. In addition, 
we were not able to assess whether children receiving influenza vaccine for the first time 
received 1 or 2 doses. Finally, statistical power may have been limited by smaller sample 
size for the analysis of whether sociodemographic/geographic characteristics were related to 
receipt of early vaccination.
Conclusion
This study focused on national trends in influenza vaccination prevalence for children with 
asthma, finding that rates have increased over time. These analyses also showed for the first 
time that only approximately 30% of children with asthma were vaccinated by the end of 
October. Further, we observed that among children with asthma, adolescents, uninsured 
children, and children in the Midwest, South, and West have lower prevalence of 
vaccination.
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From 2005 to 2013, the percentage of children with asthma receiving the influenza 
vaccination increased approximately 3 percentage points per influenza season, reaching 
55% in the 2012–2013 season. Approximately 30% of children with asthma received 
early vaccination in 2012–2013.
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Percentage of children aged 2 to 17 years with and without asthma receiving influenza 
vaccination by influenza season. Each time point represents a mutually exclusive influenza 
season. Data are from National Health Interview Survey interviews conducted during April–
July of each year, identifying whether a vaccination was received during the previous 
August–May. Gray lines represent 95% pointwise confidence bands. The percentage of all 
children aged 2 to 17 years with asthma ranged from 8.3% in during the 2006–2007 
influenza season to 11.1% during the 2008–2009 influenza season.
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